Nearly 90,000 bottles of children’s ibuprofen have been recalled over the potential presence of a foreign substance, according to the Food and Drug Administration.
Strides Pharma, Inc., headquartered in India, recalled about 89,592 bottles of its 100-milligram Children’s Ibuprofen Oral Suspension, the FDA said.
The affected product was manufactured for Taro Pharmaceuticals USA and distributed across the U.S.
The ibuprofen was sold in 4-fluid-ounce bottles at 100 milligrams per 5 milliliters.
Nearly 90,000 bottles of children’s ibuprofen have been recalled. (Getty Images / Getty Images)
The packages included the lot numbers 7261973A and 7261974A with an expiration date of Jan. 31, 2027.
The recall was first issued earlier this month after complaints of a gel-like mass and black particles in the product.
The affected product was manufactured for Taro Pharmaceuticals USA and distributed across the U.S. (iStock / iStock)
But the FDA updated the classification this week to a Class II recall, which means “use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
The Class II classification is the FDA’s second-highest urgency level.
The Class II classification is the FDA’s second-highest urgency level. (Stefani Reynolds/Bloomberg via Getty Images / Getty Images)
Consumers who purchased the recalled ibuprofen are urged to stop using it immediately.
Parents with concerns after a child has consumed the product should consult a healthcare provider.